No Data
Brokerage morning meeting highlights: The USA has increased tariffs on China, but the impact on these industries in the A-shares may be limited.
In today's brokerage morning meeting, GF SEC believes that the USA's tariffs on China have a limited impact on the A-share Computer Industry; China Securities Co.,Ltd. suggested being Bullish on the Innovative Drugs industry that is currently not affected by tariffs; Galaxy Securities stated that Deep Sea Technology has entered a new stage in Global Strategy, focusing on opportunities in core equipment.
Tong Ren Tang's 2024 Profit Declines 12%
TONG REN TANG (01666.HK) 2024 annual performance: revenue increased by 7.18% to 7.26 billion yuan, steadily advancing the Global Strategy for major products.
Gelonghui, March 28 - TONG REN TANG (01666.HK) announced its annual results. In 2024, the group will continue to deeply implement the "14th Five-Year Plan", maintaining its focus on the "TONG REN TANG Service Year" main line, and unflinchingly executing the "Big Variety" core Global Strategy. For the year ending December 31, 2024, the group's revenue was 7.26 billion RMB, an increase of 7.18% compared to the same period last year; the Net income reached 0.887 billion RMB, with a Net income attributable to owners of the company at 0.522 billion RMB, and the EPS was 0.41 RMB, with a dividend per share of 0 RMB.
Tong Ren Tang Technologies Declares Final Dividend for 2024
TONG REN TANG: Launched the "Organic Version" of the An Gong Niu Huang Wan.
To meet the market and Consumer demand for emergency medications for cardiovascular diseases, Peking TONG REN TANG Technology Development Co., Ltd. (hereinafter referred to as "TONG REN TANG") is rooted in tradition, fully leveraging the advantages of authentic medicinal materials and scientific research innovations, and has launched the An Gong Niu Huang Wan (Organic Cultivated Version). Currently, distribution has been completed in TONG REN TANG affiliated pharmacies, and work continues to implement distribution in key cooperative chains outside the system. An Gong Niu Huang Wan is a well-known product of TONG REN TANG, with the functions and indications of clearing heat and detoxifying, settling fright and opening the orifices. It is used for febrile diseases, evil entering the pericardium, high fever and convulsions, and confusion with delirium; it is also used for coma from stroke, encephalitis, meningitis, toxic encephalopathy, cerebral hemorrhage, and septicemia as mentioned above.
TONG REN TANG (01666) released its annual performance, with a net income of 0.522 billion yuan, a year-on-year decrease of 11.59%.
TONG REN TANG (01666) announced its annual performance for the year ending December 31, 2024, with the group's revenue being 72...
The Five-year Shareholder Returns and Company Earnings Persist Lower as Tong Ren Tang Technologies (HKG:1666) Stock Falls a Further 6.9% in Past Week
